Danaher Corporation (DHER34)
Market Open
14 Jan, 19:44
B3 B3 Primary R$
50. 92
-1.4
-2.68%
R$
- Market Cap
28.65 P/E Ratio
1.18% Div Yield
747 Volume
7.58 Eps
R$ 52.32
Previous Close Day Range
50.71 52.55
Year Range
39.01 57.37
Summary
DHER34 trading today lower at R$50.92, a decrease of 2.68% from yesterday's close, completing a monthly increase of 0.63% or R$0.32. Over the past 12 months, DHER34 stock gained 0.63%.
DHER34 pays dividends to its shareholders, with the most recent payment made on Oct 31, 2024. The next announced payment will be in In 3 weeks on Feb 06, 2025 for a total of R$0.03948.
Danaher Corporation has completed 1 stock splits, with the recent split occurring on Nov 21, 2022.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on B3 (BRL).
Want to track DHER34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
DHER34 Chart
FAQ
What Is the Danaher Corporation(DHER34) Stock Price Today?
The DHER34 stock price today is R$50.92.
What Stock Exchange Does Danaher Corporation Trade On?
Danaher Corporation is listed and trades on the B3.
What Is the Stock Symbol for Danaher Corporation?
The stock symbol for Danaher Corporation is "DHER34".
Does Danaher Corporation Pay Dividends? What's The Current Dividend Yield?
DHER34 is not paying dividends to its shareholders.
What Is the Danaher Corporation Market Cap?
As of today, Danaher Corporation does not have a market cap available.
Did Danaher Corporation had any splits?
Danaher Corporation had 1 splits and the recent split was on Nov 21, 2022.
Danaher Corporation Profile
| Diagnostics & Research Industry | Healthcare Sector | Mr. Rainer M. Blair CEO | B3 Exchange | - ISIN |
| United States Country | 61,000 Employees | 23 Dec 2024 Last Dividend | 21 Nov 2022 Last Split | 5 Jan 1979 IPO Date |
Overview
Danaher Corporation is a global powerhouse in the design, manufacturing, and marketing of a vast array of professional, medical, industrial, and commercial products and services. With its inception in 1969 and a significant rebranding in 1984, where it transitioned from Diversified Mortgage Investors, Inc. to Danaher Corporation, the company has established a formidable presence in various sectors. Headquartered in Washington, D.C., Danaher stands out through its commitment to innovation, excellence, and enhancing the quality of life worldwide.
Products and Services
- Biotechnology: Danaher's biotechnology segment is a provider of bioprocess technologies, consumables, and services enhancing the development and manufacture of therapeutics. This includes cell line and cell culture media development, chromatography resins, filtration technologies, aseptic fill-finish solutions, single-use hardware, and comprehensive services aimed at setting up full manufacturing suites.
- Life Sciences: This segment delivers a wide range of products including mass spectrometers, flow cytometry, genomics solutions, lab automation instruments, centrifugation, liquid handling automation instruments, antibodies and reagents, particle counting and characterization tools, microscopes, and protein consumables. Among the notable brands under the Life Sciences segment are ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX, each providing specialized products for genomic medicines and industrial filtration.
- Diagnostics: Danaher’s diagnostics sector offers a comprehensive range of chemistry, immunoassay, microbiology, automation systems, molecular diagnostics, acute care, and pathology diagnostics products. Aimed at hospitals, physicians' offices, reference laboratories, and other critical care settings, this segment ensures the delivery of clinical instruments, reagents, consumables, software, and dedicated services to support critical diagnostics.
Contact Information
Address: 2200 Pennsylvania Avenue, North West
Phone: 202 828 0850
Website: https://www.danaher.com
2025 © Marketlog. All Rights Reserved.
